薬剤注入システム市場：製品タイプ、用途、エンドユーザー別-2025-2030年の世界予測

薬剤注入システム市場は、2023年に226億1,000万米ドルと評価され、2024年には240億1,000万米ドルに達すると予測され、CAGR 6.67％で成長し、2030年には355億5,000万米ドルに達すると予測されています。

薬剤注入システムは、薬や栄養素を含む輸液を、患者の循環系に制御された方法で直接送り込むために使用される医療機器です。輸液ポンプのような医療機器は、病院、外来診療所、在宅医療などの現場で不可欠です。これらのシステムの必要性は、化学療法、麻酔、糖尿病管理などの治療に不可欠な、正確な薬物送達から生じています。最終用途としては、腫瘍学、小児科、疼痛管理、慢性疾患など様々な医療分野で使用されており、その汎用性の高さが際立っています。

薬剤注入システムの市場成長は、主に長期治療を必要とする慢性疾患の罹患率の上昇、輸液システムの技術進歩、在宅ヘルスケアへのシフトの増加といった要因の影響を受けています。さらに、医療上の複雑さを伴う老年人口の急増も需要を高めています。可能性のあるビジネスチャンスとしては、精度と患者の安全性を高めるために輸液ポンプにスマート技術と人工知能を統合することが挙げられます。ポータブルで費用対効果の高い輸液ソリューションを開発するために研究開発に投資している企業は、このダイナミックな市場環境で大きな利益を得ることができます。

逆に、市場成長を阻害する要因としては、製品承認を妨げる厳しい規制要件、高度な輸液システムに関連する高コスト、投薬ミスや機器誤作動のリスクなどが挙げられます。輸液システムの遠隔モニタリングのための無線通信技術、ヒューマンエラーを最小化するためのユーザーインターフェースデザインの改善、持続可能性への取り組みに沿った輸液デバイスの生分解性材料などの分野では、技術革新と研究が実を結ぶと思われます。

市場の競争と進化を考慮すると、企業は戦略的パートナーシップに重点を置き、適応可能な価格戦略によって製品アクセシビリティを高め、継続的な技術革新に取り組むべきです。限界に対処し、技術の進歩を活用することで、企業は薬剤注入システム分野で確固たる市場ポジションを確保することができます。

市場力学：急速に進化する薬剤注入システム市場の主要市場インサイトを公開

薬剤注入システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がん罹患率の増加と化学療法用輸液ポンプの必要性
  • 輸液ポンプの採用増加
  • 効率的で正確なドラッグデリバリーシステムに対する需要の高まりと在宅ヘルスケアへのシフト
• 市場抑制要因
  • 調達と設置にかかる初期コストの高さ
• 市場機会
  • 薬物送達技術における個別化医療のためのIoTとAIの統合の拡大
  • 薬物注入システムへの投資と研究開発の増加
• 市場の課題
  • サイバー脅威が高まる中での輸液システムの安全性と有効性の確保

ポーターのファイブフォース：薬剤注入システム市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬剤注入システム市場における外部からの影響の把握

外部マクロ環境要因は、薬剤注入システム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析薬剤注入システム市場における競合情勢の把握

薬剤注入システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス薬剤注入システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬剤注入システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨薬剤注入システム市場における成功への道筋を描く

薬剤注入システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • がんの発生率増加と化学療法輸液ポンプの必要性
    • 輸液ポンプの導入増加
    • 効率的かつ正確なドラッグデリバリーシステムに対する需要の高まりと在宅ヘルスケアへの移行
  • 抑制要因
    • 調達と設置の初期コストが高い
  • 機会
    • ドラッグデリバリー技術における個別化医療のためのIoTとAIの統合の拡大
    • 薬剤注入システムへの投資と研究開発の増加
  • 課題
    • サイバー脅威が高まる中、輸液システムの安全性と有効性を確保する
• 市場セグメンテーション分析
  • 製品タイプ：慢性疾患に関する継続的な懸念により、IVディスポーザブルの使用が増加しています。
  • 用途：最適な血糖値を維持し、糖尿病関連の合併症を最小限に抑えるために、薬剤注入システムを多用する
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 薬剤注入システム市場：製品タイプ別

• 輸液ポンプ
• IVディスポーザブル

第7章 薬剤注入システム市場：用途別

• 糖尿病
• 消化器疾患
• 腫瘍学
• 小児科

第8章 薬剤注入システム市場：エンドユーザー別

• ホームケア
• 病院
• 専門クリニック

第9章 南北アメリカの薬剤注入システム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の薬剤注入システム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬剤注入システム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • フレゼニウス・カビとメイヨー・クリニックがイベニックス輸液システムで契約を締結
  • インシュレット、アラーム制限の調整とボーラス漏れアラームを備えた輸液ポンプシステムの特許を申請
  • エイタン・メディカル、クラウドベースの輸液管理プラットフォームを発表
• 戦略分析と提言

企業一覧

• AKAS Infusions
• B. Braun SE
• Baxter International, Inc.
• Becton, Dickinson, and Company
• Debiotech S.A.
• Eitan Medical
• Flowonix Medical Inc.
• Fresenius Kabi AG
• Fresenius SE & Co. KGaA
• Halyard Health, Inc.
• ICU Medical Inc.
• Insulet Corporation
• Intera Oncology Inc.
• IRADIMED CORPORATION
• Ivenix Inc.
• Medtronic Plc
• Micrel Medical Devices SA
• Microport Scientific Corporation
• MOOG, Inc.
• Promecon GmbH
• SINO MDT
• Smiths Group plc
• Tandem Diabetes Care, Inc.
• Teleflex Incorporated
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. DRUG INFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DRUG INFUSION SYSTEMS MARKET DYNAMICS
• TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

The Drug Infusion Systems Market was valued at USD 22.61 billion in 2023, expected to reach USD 24.01 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 35.55 billion by 2030.

Drug infusion systems are medical devices used to deliver fluids, including medications and nutrients, directly into a patient's circulatory system in a controlled manner. They include devices like infusion pumps, which are essential in settings such as hospitals, outpatient clinics, and home care. The necessity of these systems arises from their precision in medication delivery, which is critical for treatments such as chemotherapy, anesthesia, and diabetes management. In terms of end use, these systems find applications in various medical fields including oncology, pediatrics, pain management, and chronic diseases, highlighting their versatile scope.

Market growth for drug infusion systems is primarily influenced by factors like the rising incidence of chronic diseases necessitating long-term treatment, technological advancements in infusion systems, and an increasing shift towards home healthcare. Additionally, the burgeoning geriatric population, with its associated medical complexities, is amplifying demand. Potential opportunities include the integration of smart technologies and artificial intelligence in infusion pumps to enhance precision and patient safety. Firms investing in R&D to develop portable and cost-effective infusion solutions stand to benefit greatly in this dynamic market environment.

Conversely, factors limiting market growth include strict regulatory requirements that can stymie product approvals, high costs associated with advanced infusion systems, and the risk of medication errors or device malfunctions. Innovation and research will be fruitful in areas such as wireless communication technologies for remote monitoring of infusion systems, improvements in user interface design to minimize human error, and biodegradable material for infusion devices to align with sustainability efforts.

Considering the competitive and evolving nature of the market, companies should focus on strategic partnerships, enhance product accessibility through adaptable pricing strategies, and engage in continuous technological innovation. By addressing the limitations and leveraging technological advancements, businesses can secure a robust market position in the drug infusion systems sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Infusion Systems Market

The Drug Infusion Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of cancer and the need for chemotherapy infusion pumps
  • Increasing adoption of infusion pumps
  • Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
• Market Restraints
  • High initial cost of procurement and installation
• Market Opportunities
  • Growing integration of IoT and AI for personalized medicine in drug delivery technologies
  • Increasing investments and R&D in drug infusion system
• Market Challenges
  • Ensuring safety and efficacy of infusion systems amid rising cyber threats

Porter's Five Forces: A Strategic Tool for Navigating the Drug Infusion Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Infusion Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Infusion Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Infusion Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Infusion Systems Market

A detailed market share analysis in the Drug Infusion Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Infusion Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Infusion Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Infusion Systems Market

A strategic analysis of the Drug Infusion Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Infusion Systems Market, highlighting leading vendors and their innovative profiles. These include AKAS Infusions, B. Braun SE, Baxter International, Inc., Becton, Dickinson, and Company, Debiotech S.A., Eitan Medical, Flowonix Medical Inc., Fresenius Kabi AG, Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., Insulet Corporation, Intera Oncology Inc., IRADIMED CORPORATION, Ivenix Inc., Medtronic Plc, Micrel Medical Devices SA, Microport Scientific Corporation, MOOG, Inc., Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Infusion Pump and IV Disposable.
• Based on Application, market is studied across Diabetes, Gastrointestinal Diseases, Oncology, and Pediatrics.
• Based on End-user, market is studied across Homecare, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of cancer and the need for chemotherapy infusion pumps
    • 5.1.1.2. Increasing adoption of infusion pumps
    • 5.1.1.3. Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. High initial cost of procurement and installation
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing integration of IoT and AI for personalized medicine in drug delivery technologies
    • 5.1.3.2. Increasing investments and R&D in drug infusion system
  • 5.1.4. Challenges
    • 5.1.4.1. Ensuring safety and efficacy of infusion systems amid rising cyber threats
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases
  • 5.2.2. Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Infusion Systems Market, by Product Type

• 6.1. Introduction
• 6.2. Infusion Pump
• 6.3. IV Disposable

7. Drug Infusion Systems Market, by Application

• 7.1. Introduction
• 7.2. Diabetes
• 7.3. Gastrointestinal Diseases
• 7.4. Oncology
• 7.5. Pediatrics

8. Drug Infusion Systems Market, by End-user

• 8.1. Introduction
• 8.2. Homecare
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Drug Infusion Systems Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Infusion Systems Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Infusion Systems Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Fresenius Kabi, Mayo Clinic Ink Deal On Ivenix Infusion System
  • 12.3.2. Insulet Files Patent On Infusion Pump System With Adjustable Alarm Limits And Missed Bolus Alarm
  • 12.3.3. Eitan Medical Launched Cloud-Based Infusion Management Platform
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AKAS Infusions
• 2. B. Braun SE
• 3. Baxter International, Inc.
• 4. Becton, Dickinson, and Company
• 5. Debiotech S.A.
• 6. Eitan Medical
• 7. Flowonix Medical Inc.
• 8. Fresenius Kabi AG
• 9. Fresenius SE & Co. KGaA
• 10. Halyard Health, Inc.
• 11. ICU Medical Inc.
• 12. Insulet Corporation
• 13. Intera Oncology Inc.
• 14. IRADIMED CORPORATION
• 15. Ivenix Inc.
• 16. Medtronic Plc
• 17. Micrel Medical Devices SA
• 18. Microport Scientific Corporation
• 19. MOOG, Inc.
• 20. Promecon GmbH
• 21. SINO MDT
• 22. Smiths Group plc
• 23. Tandem Diabetes Care, Inc.
• 24. Teleflex Incorporated
• 25. Terumo Corporation